Subacute thyroiditis after COVID-19 vaccination

Yasri, Sora; Wiwanitkit, Viroj

doi:10.1016/j.eimce.2021.12.009

ISSN: 2529-993X

The Journal Enfermedades Infecciosas y Microbiología Clínica is the official publication of the Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) (Spanish Society of Infectious Diseases and Clinical Microbiology). It has as its aim to respond to the challenges currently posed by everything associated with infectious diseases, from a clinical, microbiological and public health perspective.

The Journal follows a rigorous selection process of the manuscripts published through the review by the best experts in each area of knowledge of the specialty. The quality of the material published is the main aim of the Editors, as well as to provide readers with the latest and most relevant information in the world of infectious diseases.

Enfermedades Infecciosas y Microbiología Clínica includes the following sections: original articles, critical reviews, scientific letters, and a section dedicated to continuing medical education, which each year deals with a specific subject and a series of specific topics of the specialty, prepared by invited authors of recognised experience.

The Journal is included in Science Citation Index Expanded, Medline/PubMed, and SCOPUS.

See more Open Access Option

Indexed in:

Index Current Contents/Clinical Medicine, JCR, SCI-Expanded, Index Medicus/Medline, Excerpta Medica/EMBASE, IBECS, IME, CANCERLIT, SCOPUS

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

Impact factor 2023

2.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2023

2.1

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2023

0.355

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2023

0.381

View more metrics

Journal Information

Previous article | Next article

Vol. 40. Issue 6.

Pages 345 (June - July 2022)

Export reference

Download PDF

More article options

Statistics

Visits

603

Vol. 40. Issue 6.

Pages 345 (June - July 2022)

Letter to the Editor

DOI: 10.1016/j.eimce.2021.12.009

Full text access

Subacute thyroiditis after COVID-19 vaccination

Tiroiditis subaguda tras la vacunación con COVID-19

Visits

603

Download PDF

Sora Yasria,

Corresponding author

sorayasri@outlook.co.th

Corresponding author.

, Viroj Wiwanitkitb

a KM Center, Bangkok, Thailand

b Dr DY Patil University, Pune, India

This item has received

603 Visits

Article information

Full Text

Bibliography

Download PDF

Statistics

Full Text

Dear Editor:

We would like to share ideas on the publication “Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.1” Rebollar reported a case and mentioned for possible clinical association between thyroid problem and COVID-19 vaccination.1 Thyroid problem might be followed vaccination and the pathogenesis is still inconclusive. Regarding subacute thyroiditis, there are sporadic case reports in COVID-19 vaccine recipients.2,3 The observed thyroid abnormality might or might not be associated with vaccination. After vaccination, the abnormal thyroid function might occur and it is not related to any immunological abnormality.4 Hyperviscosity might occur after vaccination4 and it can result in an aberrantly thyroid function.5

Authors contribution

SY (50%): (1a) Substantial contributions to study conception and design. (1b) Substantial contributions to acquisition of data. (1c) Substantial contributions to analysis and interpretation of data. (2) Drafting the article or revising it critically for important intellectual content. (3) Final approval of the version of the article to be published.

VW (50%): (1a) Substantial contributions to study conception and design. (1b) Substantial contributions to acquisition of data. (1c) Substantial contributions to analysis and interpretation of data. (2) Drafting the article or revising it critically for important intellectual content. (3) Final approval of the version of the article to be published.

Funding

No funders pertaining to this article.

Conflict of interest

The authors ask for waiving for any charge relating to this correspondence.

References

[1]

A.F. Rebollar.

Subacute thyroiditis after anti-SARS-CoV-2 (Ad5-nCoV) vaccine.

Enferm Infecc Microbiol Clin, (2021),

http://dx.doi.org/10.1016/j.eimc.2021.10.015

[2]

M. Sözen, Ö. Topaloğlu, B. Çetinarslan, A. Selek, Z. Cantürk, E. Gezer, et al.